Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wanyi Situ

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Trends in Endocrinology and Metabolism: TEM|June 25, 2026
2-Methylbutyrylcarnitine (2MBC)Yanhua Liu, Wanyi Situ, Sifan Chen
Cancer Reports (Hoboken, N.J.)|December 3, 2023
A ferroptosis-related LncRNAs signature for predicting prognoses and screening potential therapeutic drugs in patients with lung adenocarcinoma: A retrospective studyJiaxin Dong, Tao Tao, Jiaao Yu, et al.
Heliyon|March 7, 2023
Risk score = LncRNAs associated with doxorubicin metabolism can be used as molecular markers for immune microenvironment and immunotherapy in non-small cell lung cancerQianyi Lin, Ming Zhang, Ying Kong, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Trends in Endocrinology and Metabolism: TEM|June 25, 2026
2-Methylbutyrylcarnitine (2MBC)Yanhua Liu, Wanyi Situ, Sifan Chen
Cancer Reports (Hoboken, N.J.)|December 3, 2023
A ferroptosis-related LncRNAs signature for predicting prognoses and screening potential therapeutic drugs in patients with lung adenocarcinoma: A retrospective studyJiaxin Dong, Tao Tao, Jiaao Yu, et al.
Heliyon|March 7, 2023
Risk score = LncRNAs associated with doxorubicin metabolism can be used as molecular markers for immune microenvironment and immunotherapy in non-small cell lung cancerQianyi Lin, Ming Zhang, Ying Kong, et al.
Pageof 1